216 related articles for article (PubMed ID: 9407562)
1. Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbations of pediatric asthma.
Lanz MJ; Leung DY; McCormick DR; Harbeck R; Szefler SJ; White CW
Pediatr Pulmonol; 1997 Nov; 24(5):305-11. PubMed ID: 9407562
[TBL] [Abstract][Full Text] [Related]
2. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children.
Lanz MJ; Leung DY; White CW
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):161-4. PubMed ID: 10071519
[TBL] [Abstract][Full Text] [Related]
3. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
4. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients.
Zietkowski Z; Bodzenta-Lukaszyk A; Tomasiak MM; Skiepko R; Szmitkowski M
J Investig Allergol Clin Immunol; 2006; 16(4):239-46. PubMed ID: 16889281
[TBL] [Abstract][Full Text] [Related]
5. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule.
Kunkel G; Rydén AC
Inflamm Res; 1999 Feb; 48(2):94-100. PubMed ID: 10202995
[TBL] [Abstract][Full Text] [Related]
6. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
[TBL] [Abstract][Full Text] [Related]
7. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children.
Piacentini GL; Bodini A; Costella S; Vicentini L; Mazzi P; Sperandio S; Boner AL
Eur Respir J; 1999 Jun; 13(6):1386-90. PubMed ID: 10445616
[TBL] [Abstract][Full Text] [Related]
8. Exhaled nitric oxide, serum ECP and airway responsiveness in mild asthmatic children.
Piacentini GL; Bodini A; Costella S; Suzuki Y; Zerman L; Peterson CG; Boner AL
Eur Respir J; 2000 May; 15(5):839-43. PubMed ID: 10853846
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide is associated with allergic inflammation in children.
Choi BS; Kim KW; Lee YJ; Baek J; Park HB; Kim YH; Sohn MH; Kim KE
J Korean Med Sci; 2011 Oct; 26(10):1265-9. PubMed ID: 22022176
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroids decrease exhaled nitric oxide in children with acute asthma.
Baraldi E; Azzolin NM; Zanconato S; Dario C; Zacchello F
J Pediatr; 1997 Sep; 131(3):381-5. PubMed ID: 9329413
[TBL] [Abstract][Full Text] [Related]
11. Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children.
Carrà S; Gagliardi L; Zanconato S; Scollo M; Azzolin N; Zacchello F; Baraldi E
Respir Med; 2001 Sep; 95(9):734-9. PubMed ID: 11575894
[TBL] [Abstract][Full Text] [Related]
12. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR
Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563
[TBL] [Abstract][Full Text] [Related]
13. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.
Strunk RC; Szefler SJ; Phillips BR; Zeiger RS; Chinchilli VM; Larsen G; Hodgdon K; Morgan W; Sorkness CA; Lemanske RF;
J Allergy Clin Immunol; 2003 Nov; 112(5):883-92. PubMed ID: 14610474
[TBL] [Abstract][Full Text] [Related]
14. Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics.
Dal Negro R; Micheletto C; Tognella S; Turco P; Rossetti A; Cantini L
Allergy; 2003 Oct; 58(10):1018-22. PubMed ID: 14510719
[TBL] [Abstract][Full Text] [Related]
15. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma.
Niimi A; Amitani R; Suzuki K; Tanaka E; Murayama T; Kuze F
Clin Exp Allergy; 1998 Feb; 28(2):233-40. PubMed ID: 9515598
[TBL] [Abstract][Full Text] [Related]
16. Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide.
Stelmach I; Jerzynska J; Kuna P
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):319-26. PubMed ID: 11686425
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma.
Türktaş I; Demirsoy S; Koç E; Gökçora N; Elbeg S
Arch Dis Child; 1996 Oct; 75(4):314-8. PubMed ID: 8984917
[TBL] [Abstract][Full Text] [Related]
18. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma.
Lehtimäki L; Kankaanranta H; Saarelainen S; Turjanmaa V; Moilanen E
Eur Respir J; 2001 Oct; 18(4):635-9. PubMed ID: 11716167
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
Stelmach I; Jerzynska J; Kuna P
J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
[TBL] [Abstract][Full Text] [Related]
20. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.
Vatrella A; Ponticiello A; Parrella R; Romano L; Zofra S; DiLeva A; Bariffi F
Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
